{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:25:46Z","timestamp":1790983546417,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T00:00:00Z","timestamp":1418428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00424-014-1658-0","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T20:41:25Z","timestamp":1418330485000},"page":"587-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Primary aldosteronism and salt"],"prefix":"10.1007","volume":"467","author":[{"given":"John W.","family":"Funder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,13]]},"reference":[{"issue":"8","key":"1658_CR1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","volume":"99","author":"AH Ahmed","year":"2014","unstructured":"Ahmed AH, Cowley D, Wolley M, Gordon RD, Xu S, Taylor PJ, Stowasser M (2014) Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study. J Clin Endocrinol Metab 99(8):2745\u20132753. doi: 10.1210\/jc.2014-1153","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1658_CR2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HJH.0b013e32835d6d49","volume":"31","author":"L Amar","year":"2013","unstructured":"Amar L, Azizi M, Menard J, Peyrard S, Plouin PF (2013) Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism. J Hypertens 31(3):624\u2013629. doi: 10.1097\/HJH.0b013e32835d6d49 , discussion 629","journal-title":"J Hypertens"},{"issue":"4812","key":"1658_CR3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","volume":"237","author":"JL Arriza","year":"1987","unstructured":"Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237(4812):268\u2013275","journal-title":"Science"},{"issue":"9","key":"1658_CR4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/ajh\/hpu126","volume":"27","author":"K Asayama","year":"2014","unstructured":"Asayama K, Stolarz-Skrzypek K, Persu A, Staessen JA (2014) Systematic review of health outcomes in relation to salt intake highlights the widening divide between guidelines and the evidence. Am J Hypertens 27(9):1138\u20131142. doi: 10.1093\/ajh\/hpu126","journal-title":"Am J Hypertens"},{"issue":"6","key":"1658_CR5","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT (1992) Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 120(6):893\u2013901","journal-title":"J Lab Clin Med"},{"issue":"1","key":"1658_CR6","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW (1955) Primary Aldosteronism, a new clinical syndrome. J Lab Med 45(1):3\u201317","journal-title":"J Lab Med"},{"issue":"44","key":"1658_CR7","doi-asserted-by":"crossref","first-page":"15845","DOI":"10.1073\/pnas.0507358102","volume":"102","author":"I Dostanic-Larson","year":"2005","unstructured":"Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB (2005) The highly conserved cardiac glycoside binding site of Na, K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci U S A 102(44):15845\u201315850","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8618","key":"1658_CR8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","volume":"2","author":"CR Edwards","year":"1988","unstructured":"Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C (1988) Localisation of 11 beta-hydroxysteroid dehydrogenase\u2014tissue specific protector of the mineralocorticoid receptor. Lancet 2(8618):986\u2013989","journal-title":"Lancet"},{"issue":"3","key":"1658_CR9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2337\/dc10-1723","volume":"34","author":"EI Ekinci","year":"2011","unstructured":"Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G (2011) Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 34(3):703\u2013709. doi: 10.2337\/dc10-1723","journal-title":"Diabetes Care"},{"issue":"3","key":"1658_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0031-1301281","volume":"44","author":"JW Funder","year":"2012","unstructured":"Funder JW (2012) Primary aldosteronism: are we missing the wood for the trees? Horm Metab Res 44(3):251\u2013253. doi: 10.1055\/s-0031-1301281","journal-title":"Horm Metab Res"},{"key":"1658_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IBPC.S13783","volume":"6","author":"JW Funder","year":"2013","unstructured":"Funder JW (2013) Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine. Integr Blood Press Control 6:129\u2013138. doi: 10.2147\/IBPC.S13783 , Review","journal-title":"Integr Blood Press Control"},{"issue":"6","key":"1658_CR12","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.114.03127","volume":"63","author":"JW Funder","year":"2014","unstructured":"Funder JW (2014) Sensitivity to aldosterone: plasma levels are not the full story. Hypertension 63(6):1168\u20131170. doi: 10.1161\/HYPERTENSIONAHA.114.03127","journal-title":"Hypertension"},{"key":"1658_CR13","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C et al (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266\u20133281. doi: 10.1210\/jc.2008-0104","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1658_CR14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/endo-92-4-994","volume":"92","author":"JW Funder","year":"1973","unstructured":"Funder JW, Feldman D, Edelman IS (1973) The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 92(4):994\u20131004","journal-title":"Endocrinology"},{"issue":"4878","key":"1658_CR15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"JW Funder","year":"1988","unstructured":"Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242(4878):583\u2013585","journal-title":"Science"},{"issue":"4 Pt 1","key":"1658_CR16","first-page":"E649","volume":"258","author":"EP G\u00f3mez-S\u00e1nchez","year":"1990","unstructured":"G\u00f3mez-S\u00e1nchez EP, Venkataraman MT, Thwaites D, Fort C (1990) ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 258(4 Pt 1):E649\u2013E653","journal-title":"Am J Physiol"},{"issue":"11","key":"1658_CR17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1365-2362.2011.02531.x","volume":"41","author":"A Gouli","year":"2011","unstructured":"Gouli A, Kaltsas G, Tzonou A et al (2011) High prevalence of autonomous aldosterone secretion among patients with essential hypertension. Eur J Clin Investig 41(11):1127\u20131136. doi: 10.1111\/j.1365-2362.2011.02531.x","journal-title":"Eur J Clin Investig"},{"key":"1658_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","volume":"44","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Wallaschofski H (2012) Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2014a review of the current literature. Horm Metab Res 44:157\u2013162. doi: 10.1055\/s-0031-1295438","journal-title":"Horm Metab Res"},{"issue":"4","key":"1658_CR19","first-page":"419","volume":"3","author":"T Hasegawa","year":"1987","unstructured":"Hasegawa T, Masugi F, Ogihara T, Kumahara Y (1987) Increase in plasma ouabainlike inhibitor of Na+, K+\u2212ATPase with high sodium intake in patients with essential hypertension. J Clin Hypertens 3(4):419\u2013429","journal-title":"J Clin Hypertens"},{"key":"1658_CR20","first-page":"CD004937","volume":"4","author":"FJ He","year":"2013","unstructured":"He FJ, Li J, Macgregor GA (2013) Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 4:CD004937. doi: 10.1002\/14651858.CD004937.pub2 , Review","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1658_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","volume":"58","author":"A Helber","year":"1980","unstructured":"Helber A, Wambach G, Hummerich W, B\u0161nner G, Meurer KA, Kaufmann W (1980) Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading. Klin Wochenschr 58(9):439\u2013447, No abstract available","journal-title":"Klin Wochenschr"},{"key":"1658_CR22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyana T (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141:1589\u20131593","journal-title":"Arch Intern Med"},{"issue":"1","key":"1658_CR23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","volume":"34","author":"Y Ito","year":"2011","unstructured":"Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y (2011) Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res 34(1):98\u2013102. doi: 10.1038\/hr.2010.166","journal-title":"Hypertens Res"},{"key":"1658_CR24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3181\/00379727-115-29052","volume":"115","author":"CMBD Kagawa","year":"1964","unstructured":"Kagawa CMBD (1964) Relationship of plasma aldadiene levels and antimineralocorticoid effects of spironolactone in the laboratory. Proc Soc Exp Biol Med 115:837\u2013840","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10","key":"1658_CR25","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/HJH.0b013e3283559a03","volume":"30","author":"NM Kaplan","year":"2012","unstructured":"Kaplan NM (2012) Primary aldosteronism: evidence against a second epidemic. J Hypertens 30(10):1899\u20131902. doi: 10.1097\/HJH.0b013e3283559a03","journal-title":"J Hypertens"},{"issue":"5","key":"1658_CR26","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1210\/en.2010-1444","volume":"152","author":"KS Kassahn","year":"2011","unstructured":"Kassahn KS, Ragan MA, Funder JW (2011) Mineralocorticoid receptors: evolutionary and pathophysiological considerations. Endocrinology 152(5):1883\u20131890. doi: 10.1210\/en.2010-1444","journal-title":"Endocrinology"},{"issue":"5","key":"1658_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outhousden L, van der Wilt GJ, Schultze Kool LJ, Hermus KR, Deinum J (2009) Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 151(5):329\u2013337, Review","journal-title":"Ann Intern Med"},{"issue":"19","key":"1658_CR28","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","volume":"80","author":"ZS Krozowski","year":"1983","unstructured":"Krozowski ZS, Funder JW (1983) Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci U S A 80(19):6056\u20136060","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1658_CR29","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","volume":"97","author":"EM K\u00ffpers","year":"2012","unstructured":"K\u00ffpers EM, Amar L, Raynaud A, Plouin PF, Steichen O (2012) A clinical prediction score to diagnose unilateral primary aldosteronism. J Clin Endocrinol Metab 97(10):3530\u20133537. doi: 10.1210\/jc.2012-1917","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 Pt 2","key":"1658_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.HYP.29.1.401","volume":"29","author":"J Laredo","year":"1997","unstructured":"Laredo J, Shah JR, Lu ZR, Hamilton BP, Hamlyn JM (1997) Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 29(1 Pt 2):401\u2013407","journal-title":"Hypertension"},{"issue":"6","key":"1658_CR31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/HYPERTENSIONAHA.111.190488","volume":"59","author":"TY Loan Le","year":"2012","unstructured":"Le Loan TY, Mardini M, Howell VM, Funder JW, Ashton AW, Mihailidou AS (2012) Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarction. Hypertension 59(6):1164\u20131169. doi: 10.1161\/HYPERTENSIONAHA.111.190488","journal-title":"Hypertension"},{"key":"1658_CR32","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","volume":"89","author":"D Levy","year":"2004","unstructured":"Levy D, Rocha R, Funder JW (2004) Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab 89:2736\u20132740","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1658_CR33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Sch\u0178tz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83(6):835\u2013839","journal-title":"Cell"},{"issue":"6","key":"1658_CR34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","volume":"54","author":"AS Mihailidou","year":"2009","unstructured":"Mihailidou AS, Le TYL, Mardini M, Funder JW (2009) Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54(6):1306\u20131312. doi: 10.1161\/HYPERTENSIONAHA.109.136242","journal-title":"Hypertension"},{"issue":"8","key":"1658_CR35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45(8):1243\u20131248","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1658_CR36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A (2011) Task force committee on primary Aldosteronism, the Japan endocrine society. Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J 58(9):711\u2013721","journal-title":"Endocr J"},{"issue":"11 Pt 1","key":"1658_CR37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","volume":"16","author":"MK Nishizaka","year":"2003","unstructured":"Nishizaka MK, Zaman MA, Calhoun DA (2003) Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 16(11 Pt 1):925\u2013930","journal-title":"Am J Hypertens"},{"issue":"7","key":"1658_CR38","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","volume":"28","author":"Y Ori","year":"2013","unstructured":"Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H (2013) Regression of left ventricular hypertrophy in patients with primary aldosteronism\/low-renin hypertension on low-dose spironolactone. Nephrol Dial Transplant 28(7):1787\u20131793. doi: 10.1093\/ndt\/gfs587","journal-title":"Nephrol Dial Transplant"},{"issue":"31","key":"1658_CR39","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","volume":"34","author":"B Pitt","year":"2013","unstructured":"Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F (2013) Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94\u20138862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J 34(31):2453\u20132463. doi: 10.1093\/eurheartj\/eht187","journal-title":"Eur Heart J"},{"key":"1658_CR40","unstructured":"Pollan M (2013) Cooked: a natural history of transformation. Penguin, New York"},{"issue":"1","key":"1658_CR41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","volume":"93","author":"W Qin","year":"2003","unstructured":"Qin W, Rudolph AE, Bond BR, Rocha R, Blomme EA, Goellner JJ, Funder JW, McMahon EG (2003) Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 93(1):69\u201376","journal-title":"Circ Res"},{"issue":"3","key":"1658_CR42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","volume":"54","author":"AJ Rickard","year":"2009","unstructured":"Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ (2009) Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54(3):537\u2013543. doi: 10.1161\/HYPERTENSIONAHA.109.131110","journal-title":"Hypertension"},{"issue":"6","key":"1658_CR43","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1210\/jc.2013-3789","volume":"99","author":"A Riester","year":"2014","unstructured":"Riester A, Fischer E, Degenhart C, Reiser MF, Bidlingmaier M, Beuschlein F, Reincke M, Quinkler M (2014) Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. J Clin Endocrinol Metab 99(6):E1035\u2013E1039. doi: 10.1210\/jc.2013-3789","journal-title":"J Clin Endocrinol Metab"},{"key":"1658_CR44","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 48:2293\u20132300","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1658_CR45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin PF, Steichen O (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62(2):331\u2013336. doi: 10.1161\/HYPERTENSIONAHA.113.01060","journal-title":"Hypertension"},{"issue":"9","key":"1658_CR46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","volume":"9","author":"SA Simpson","year":"1953","unstructured":"Simpson SA, Tait JF, Wettstein A, Neher R, Von Euw J, Reichstein T (1953) Isolierung eines neuen kristallisierten Hormons aus Nebennerien mit besonders hoher Wirksamkeit auf din Mineralsoffwechsel. Experientia 9(9):333\u2013335","journal-title":"Experientia"},{"issue":"9","key":"1658_CR47","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"90","author":"M Stowasser","year":"2005","unstructured":"Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH (2005) Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90(9):5070\u20135076","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1658_CR48","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","volume":"63","author":"W Tu","year":"2014","unstructured":"Tu W, Eckert GJ, Hannon TS, Liu H, Pratt LM, Wagner MA, Dimeglio LA, Jung J, Pratt JH (2014) Racial differences in sensitivity of blood pressure to aldosterone. Hypertension 63(6):1212\u20131218. doi: 10.1161\/HYPERTENSIONAHA.113.02989","journal-title":"Hypertension"},{"issue":"7","key":"1658_CR49","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1210\/en.2004-0005","volume":"145","author":"M Young","year":"2004","unstructured":"Young M, Funder JW (2004) Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone\/salt-treated rats. Endocrinology 145(7):3153\u20133157","journal-title":"Endocrinology"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-014-1658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-014-1658-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-014-1658-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:57:19Z","timestamp":1559062639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-014-1658-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,13]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1658"],"URL":"https:\/\/doi.org\/10.1007\/s00424-014-1658-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725278215.793502826","asserted-by":"object"}]},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,13]]}}}